Document:

EX-10.6

 Exhibit 10.6 

MERIDIAN BIOSCIENCE, INC. 

ISRAELI APPENDIX 
 TO THE

 MERIDIAN BIOSCIENCE, INC. 2012 STOCK INCENTIVE PLAN 
  

	 	1.	 Special Provisions for Persons who are Israeli Taxpayers. 

1.1    This Israeli Appendix (the “Appendix”) to the Meridian Bioscience, Inc. 2012 Stock
Incentive Plan, as amended from time to time (the “Plan”) is made and entered effective as of July 10, 2020 (the “Appendix Effective Date”). The provisions specified hereunder shall form an integral part
of the Plan. 
 1.2    The provisions set forth in this Appendix apply only to Participants who are
subject to taxation by the State of Israel with respect to Awards granted thereto (each, an “Israeli Participant”). 

1.3    This Appendix applies with respect to Awards granted under the Plan as aforesaid. The purpose of
this Appendix is to establish certain rules and limitations applicable to Awards that may be granted under the Plan to Israeli Participants from time to time, in compliance with the securities and other applicable laws currently in force in the
State of Israel. All grants made pursuant to this Appendix shall be governed by the terms of the Plan and the terms of this Appendix. This Appendix is applicable only to grants made after the Appendix Effective Date. This Appendix is subject to the
ITO (as defined below) and Section 102 (as defined below) in particular. 
 1.4    The Plan and
this Appendix shall be read together with respect to Israeli Participants. In the event of a conflict between this Appendix and the Plan, this Appendix shall take precedence with respect to provisions relating to Section 102. 

 

	 	2.	 Definitions. 

Capitalized terms not otherwise defined herein shall have the meaning assigned to them in the Plan. The following additional
definitions will apply to grants made pursuant to this Appendix: 
 “3(i) Grant” means an Award that is
subject to taxation pursuant to Section 3(i) of the ITO which has been granted to any person who is NOT an Eligible 102 Participant. 

“102 Capital Gains Track” means the tax track set forth in Section 102(b)(2) or Section 102(b)(3)
of the ITO, as the case may be. 
 “102 Capital Gains Track Grant” means a 102 Trustee Grant elected and
designated to qualify for the special tax treatment under the 102 Capital Gains Track. 
 “102 Earned Income
Track” means the tax track set forth in Section 102(b)(1) of the ITO. 
 “102 Earned Income Track
Grant” means a 102 Trustee Grant elected and designated to qualify for the ordinary income tax treatment under the 102 Earned Income Track. 

“102 Trustee Grant” means an Award granted pursuant to Section 102(b) of the ITO and held in trust by a
Trustee for the benefit of the Eligible 102 Participant, and includes 102 Capital Gains Track Grants and 102 Earned Income Track Grants, if and as applicable. 

“Affiliated Company” means any legal entity that qualifies as an “employing company” within
the meaning of Section 102(a) of the ITO. 

 “Controlling Shareholder” as defined under
Section 32(9) of the ITO. 
 “Election” means the Company’s election of the type (i.e., between
102 Capital Gains Track or 102 Earned Income Track) of 102 Trustee Grants that it will make under the Plan, as filed with the ITA. 

“Eligible 102 Participant” means each of: (i) an individual who is employed by the Company or an Israeli
resident Affiliated Company, and (ii) an individual who is serving as an office holder (including, for the removal of a doubt, a director) of the Company or an Israeli resident Affiliated Company – in each case (both (i) and (ii)
above) - who is not a Controlling Shareholder. 
 “Fair Market Value” means, without derogating from the
definition in the Plan of the term of “Fair Market Value” and solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, as follows: if at the Date of Grant the Company’s shares are
listed on any established stock exchange or a national market system or if the Company’s shares will be registered for trading within ninety (90) days following the Date of Grant, the Fair Market Value of a Common Share on the date of
grant shall be determined in accordance with the average value of the Company’s shares on the thirty (30) trading days preceding the Date of Grant or on the thirty (30) trading days following the date of registration for trading, as
the case may be. 
 “ITA” means the Israeli Tax Authority. 

“ITO” or the “Ordinance” means the Israeli Income Tax Ordinance (New Version), 5721-1961 and
the rules, regulations, orders or procedures promulgated thereunder and any amendments thereto, including specifically the ITO Rules, all as may be amended from time to time. 

“ITO Rules” means the Income Tax Rules (Tax Benefits in Share Issuance to Employees), 5763-2003. 

“Non-Trustee Grant” means an Award granted to an Eligible 102
Participant pursuant to Section 102(c) of the ITO. 
 “Participant” shall have the meaning ascribed to
such term in the Plan, provided, however, that for the purpose of this Appendix, it is hereby clarified that any reference to the term “Company” in Section 4 of the Plan, and consequently, to the definition
of a Participant, shall be deemed to specifically include also any and all Affiliated Companies, whether those are captured or not in the definition of the term Company in the Plan. 

“Required Holding Period” means the requisite period prescribed by Section 102 and the ITO Rules, or
such other period as may be required by the ITA, with respect to 102 Trustee Grants, during which an Award granted by the Company and the Common Share issued or delivered upon the exercise (in the case of Stock Options) or vesting and settlement (in
the case of Restricted Share Units) of such Award must be held by the Trustee for the benefit of the person to whom it was granted. As of the Appendix Effective Date, the Required Holding Period for 102 Capital Gains Track Grants is 24 months from
the date the Award is granted and deposited with the Trustee, provided that all the conditions set forth in Section 102 and the related regulations have been fulfilled. 

“Section 102” means the provisions of Section 102 of the ITO, as amended from time to
time. 
 “Trustee” means a person or entity designated by the Board or the Committee to serve as a trustee
and/or supervising trustee and approved by the ITA in accordance with the provisions of Section 102(a) of the ITO. 

  
 2 

 “Trust Agreement” means the agreement(s) between the
Company and/or an Affiliated Company and the Trustee, regarding Awards granted under this Appendix, as in effect from time to time. 
  

	 	3.	 Types of Grants and Section 102 Election.

 3.1    Grants of Awards made pursuant to Section 102, shall be made pursuant
to either (a) Section 102(b)(2) or Section 102(b)(3) of the ITO, as the case may be, as 102 Capital Gains Track Grants, or (b) Section 102(b)(1) of the ITO as 102 Earned Income Track Grants. The Company’s Election
regarding the type of 102 Trustee Grant it elects to make shall be filed with the ITA before any grant is made pursuant to such Election in accordance with Section 102 and shall also be applicable to any stock dividend and/or additional rights
that are granted with respect to an Award which was granted as a 102 Trustee Grant. Once the Company has filed such Election, it may change the type of 102 Trustee Grant that it elects to make only in accordance with the provisions of
Section 102(g) of the ITO (i.e., after the lapse of at least 12 months from the end of the calendar year in which the first grant was made pursuant to the previous Election). For the avoidance of doubt, such Election shall not prevent the
Company from granting Non-Trustee Grants to Eligible 102 Participants at any time. 

3.2    Eligible 102 Participants may receive only 102 Trustee Grants or
Non-Trustee Grants under this Appendix. Israeli Participants who are not Eligible 102 Participants may be granted only 3(i) Grants under this Appendix. 

3.3    No 102 Trustee Grants may be made effective pursuant to this Appendix until 30 days after the
requisite filings required by the ITO and the ITO Rules have been filed with the ITA; provided, however, that if the ITA provides approval for such - 102 Trustee Grants may be made effective prior to the lapse of the aforementioned 30 day period.

 3.4    The Award Agreement or other documents evidencing an Award granted or Common Shares issued or
delivered pursuant to the Plan and this Appendix shall indicate, among others, whether the grant is a 102 Trustee Grant, a Non-Trustee Grant or a 3(i) Grant; and, if the grant is a 102 Trustee Grant, whether
it is a 102 Capital Gains Track Grant or a 102 Earned Income Track Grant, the vesting provisions, the settlement provisions and the exercise price (if any and as applicable). For the avoidance of doubt, each Eligible 102 Participant granted a 102
Trustee Grant, shall be required to sign and deliver to the Trustee a consent letter (whether as part of the Award Agreement or as a stand-alone consent, as the case may be) which includes several statements under which the Israeli Participant,
among others, (i) agrees to be subject to the Trust Agreement and agrees that the Trustee be released from any liability in respect of any action or decision duly taken and bona fide executed by it with respect to the Plan, this Appendix and/or
any 102 Trustee Grants; (ii) declares that he/she understands and accepts the provisions of Section 102 and the applicable tax track and approves the tax arrangement contemplated thereby; and (iii) confirms that he/she shall neither
sell nor transfer the Common Shares or any other right attributed thereto until the lapse of the Required Holding Period. 
  

	 	4.	 Terms And Conditions of 102 Trustee Grants. 

4.1    Each 102 Trustee Grant will be deemed granted on the date of, or the date stated in, the applicable
Board or Committee resolution (as applicable) (i.e., the Date of Grant), in accordance with the provisions of Section 102 and the Trust Agreement. 

4.2    Each 102 Trustee Grant, and any stock dividend and/or additional rights that are granted with
respect to an Award which was granted as a 102 Trustee Grant, granted to an Eligible 102 Participant shall be held by the Trustee and each Common Share acquired pursuant to a 102 Trustee Grant shall be deposited in a trust account in the name of a
Trustee and shall be held in trust for the benefit of the Eligible 102 Participant for the Required Holding Period. After the lapse of the Required Holding Period, the Trustee may release such Award and any such Common Shares, provided that (i)

  
 3 

 
the Trustee has received an acknowledgment from the ITA that the Eligible 102 Participant has paid any applicable tax due pursuant to the ITO; or (ii) the Trustee and/or the Company and/or
the applicable Affiliated Company withhold any applicable tax due pursuant to the ITO. The Trustee shall not release any Award which is granted pursuant to a 102 Trustee Grant, or Common Shares issued thereunder and held by it, prior to the full
payment of the Eligible 102 Participant’s tax liabilities. 
 4.3    Each 102 Trustee Grant
(whether a 102 Capital Gains Track Grant or a 102 Earned Income Track Grant, as applicable), and any stock dividend and/or additional rights that are granted with respect to an Award which was granted as a 102 Trustee Grant, shall be subject to the
relevant terms of Section 102 and the ITO, which shall be deemed an integral part of the 102 Trustee Grant and shall prevail over any term contained in the Plan, this Appendix or any Award Agreement that is not consistent therewith. Any
provision of the ITO and any approvals by the ITA not expressly specified in this Appendix or any document evidencing a grant that are necessary to receive or maintain any tax benefit pursuant to Section 102, shall be binding on the Eligible
102 Participant. The Trustee and each Eligible 102 Participant who is granted a 102 Trustee Grant shall comply with the ITO and the terms and conditions of the Trust Agreement entered into between the Company and the Trustee. For avoidance of doubt,
it is reiterated that compliance with the ITO specifically includes compliance with the ITO Rules. Further, the Eligible 102 Participant agrees to execute any and all documents which the Company, the applicable Affiliated Company or the Trustee may
reasonably determine to be necessary in order to comply with the provision of any applicable law, and, particularly, Section 102. 

4.4    During the Required Holding Period, the Eligible 102 Participant shall not require the Trustee to
release or sell the Award or the underlying Common Shares and other shares received subsequently following any realization of rights derived from Award or Common Shares (including stock dividends) to the Eligible 102 Participant or to a third party.
Notwithstanding the foregoing, the Trustee may, pursuant to a written request and subject to applicable law, release and transfer such Common Shares to a designated third party, provided that both of the following conditions have been fulfilled
prior to such transfer: (i) all taxes required to be paid upon the release and transfer of the Common Shares have been withheld for transfer to the ITA; and (ii) the Trustee has received written confirmation from the Company and the
applicable Affiliated Company that all requirements for such release and transfer have been fulfilled according to the terms of the Company’s corporate documents, the Plan, this Appendix, any applicable agreement and any applicable law. To
avoid doubt, such sale or release during the Required Holding Period will result in different tax ramifications to the Eligible 102 Participant under Section 102 of the ITO and the ITO Rules and/or any other regulations or orders or procedures
promulgated thereunder, which shall apply to and shall be borne solely by such Eligible 102 Participant. 

4.5    In the event a stock dividend is declared and/or additional rights are granted with respect to
Common Shares which were issued upon an exercise or vesting and settlement of an Award which was granted as a 102 Trustee Grant, such stock dividend and/or rights shall also be subject to the provisions of this Section 4
and the Required Holding Period for such stock dividend and/or rights shall be measured from the commencement of the Required Holding Period for the Award with respect to which the stock dividend was declared and/or rights granted. In the event of a
cash dividend which applies to an Award or Common Shares, the Trustee and/or the Company and/or the Affiliated Companies shall deduct all taxes and mandatory payments from the dividend proceeds in compliance with applicable withholding requirements
before transferring the dividend proceeds to the Eligible 102 Participant. 
 4.6    If an Award which
is granted as a 102 Trustee Grant is exercised (in the case of Stock Options) or vests and settled (in the case of Restricted Share Units) during the Required Holding Period, the Common Shares issued or delivered upon such exercise or vesting and
settlement, if and as applicable, shall be issued or delivered, as applicable, in the name of the Trustee for the benefit of the Eligible 102 Participant. If such Common Shares are issued or delivered, as applicable, after the Required Holding
Period has lapsed, the Common Shares issued or delivered, as applicable, upon such 

  
 4 

 
exercise or vesting and settlement shall, at the election of the Eligible 102 Participant, either (i) be issued or delivered, as applicable, in the name of the Trustee, or (ii) be
transferred to the Eligible 102 Participant directly, provided that the Eligible 102 Participant first complies with all applicable provisions of the Plan, this Appendix and Section 102, and the Eligible 102 Participant pays all taxes which
apply on the Common Shares or to such transfer of Common Shares. 
 4.7    To avoid doubt, in the event
that an Award granted to Eligible 102 Participants pursuant to the Plan and this Appendix, is settled for cash (including, but not limited to, Restricted Share Units which may be settled in cash, as stipulated in Section 6(c)(v) of the Plan),
such Award most likely will not be qualified as a 102 Trustee Grant. It is also clarified that various amendments to the Plan or to the terms of an Award that has already been granted, as well as the performance of some of the procedures stipulated
in the Plan or the resolution of the Administrator to condition an Award with various terms and conditions may be subject to obtaining the prior-approval (ruling) of the ITA as a condition to having the 102 Capital Gains Track Grants continue to be
subject to the 102 Capital Gains Track, including, without limitation, any process of (i) repricing (including as stipulated in Section 6(a)(v) of the Plan or any equivalent thereof), (ii) acceleration of vesting that has not been
originally stipulated in the Award Agreement, (iii) cashless exercise (including as stipulated in Section 6(a)(vi)(A) of the Plan or any equivalent thereof), (iv) adjustments to the Exercise Price (including as stipulated in Section 8
of the Plan), whether pursuant to a distribution of dividend or changes in the Company’s capital structure, and (v) any performance-based vesting (including any vesting that relies on Performance Goals, restrictions based upon the
achievement of specific performance goals as stipulated in Section 6(c)(ii) or the Plan or any equivalent thereof). 

Notwithstanding anything to the contrary in the Plan or this Appendix, it is hereby clarified that no “put” or
“call” option provisions are deemed included in the Plan or this Appendix with respect to Awards which are intended to qualify as 102 Trustee Grants without first obtaining the prior approval from the ITA. 

4.8    Upon receipt of a 102 Trustee Grant, the Eligible 102 Participant will sign an undertaking to
release the Trustee, the Company and the Affiliated Companies from any liability in respect of any action or decision duly taken and bona fide executed in relation with this Appendix, or any 102 Trustee Grant Common Share granted to the Eligible 102
Participant thereunder. 
  

	 	5.	 Exercise Of Awards. 

Awards shall be exercised by the Eligible 102 Participant by giving written notice to the Company and/or to any third party
designated by the Company (the “Representative”), in such form and method as may be determined by the Company (and subject to the terms stipulated in the Plan and/or in such form) and, when applicable, by the Trustee, in accordance
with the requirements of Section 102, which exercise shall be effective – except if otherwise set forth in the said form of notice - upon receipt of such notice by the Company and/or the Representative and the payment of the exercise price
(if any) for the number of Common Shares with respect to which the Award is being exercised, at the Company’s or the Representative’s principal office. The notice shall specify the number of Common Shares with respect to which the Award is
being exercised. Awards that are not required to be exercised, but rather become payable in accordance with the terms and conditions of the Award shall be settled in cash (without, for the removal of a doubt, derogating from the provisions of
Sections 4.7 and 7 hereof), Common Shares, Restricted Shares, or a combination thereof, as determined by the Company. 
  

	 	6.	 Assignability. 

As long as an Award or Common Shares are held by the Trustee on behalf of the Eligible 102 Participant, none of the rights of
the Eligible 102 Participant over the Award or the Common Shares nor any rights attributed thereto or derived therefrom may be (i) sold, assigned, pledged, given as collateral or mortgaged or otherwise transferred, other than by will or by
operation of law, (ii) subject 

  
 5 

 
of an attachment, power of attorney, a proxy or a share transfer deed (other than a power of attorney or a proxy or a voting agreement with respect to the Common Shares which was pre-approved by the Company) unless Section 102 and/or any tax ruling issued by the ITA with respect to 102 Trustee Grants allow otherwise. During the lifetime of the Eligible 102 Participant, each and all of
such Eligible 102 Participant’s rights to purchase, or be delivered with, Common Shares under the Plan and this Appendix shall be exercisable by, or be delivered for the benefit of, the Eligible 102 Participant only. Any such action made
directly or indirectly, for an immediate validation or for a future one, shall be void. 
  

	 	7.	 Tax Consequences. 

7.1    Any tax consequences arising from the grant or exercise or vesting or settlement of any Award, from
the payment for Common Shares covered thereby, or from any other event or act (of the Company, and/or its applicable Affiliated Company, and the Trustee or the Israeli Participant), hereunder, shall be borne solely by the Israeli Participant. The
Company and/or its Affiliated Companies, and/or the Trustee shall be entitled to withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source. Furthermore, the Israeli
Participant shall agree to indemnify the Company and/or its Affiliated Companies and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation,
liabilities relating to (i) the necessity to withhold, or to have withheld, any such tax from any payment made to the Israeli Participant, (ii) any taxes that should have been paid by the Israeli Participant in connection with the transfer
of the Awards from the Trustee to a designated transferee, whether or not a payment was deemed to be made as part of such transfer, and (iii) any taxes that the Israeli Participant should have paid upon the exercise of the Awards into Common
Shares or settlement of Awards for Common Shares, if and as applicable. The Company and/or any of its Affiliated Companies and/or the Trustee may make such provisions and take such steps as it may deem necessary or appropriate for the withholding of
all taxes required by law to be withheld with respect to an Award granted under the Plan and this Appendix and the exercise or vesting or sale or settlement thereof, including, but not limited, to (i) deducting the amount so required to be
withheld from any other amount then or thereafter payable to an Israeli Participant, and/or (ii) requiring an Israeli Participant to pay to the Company or any of its Affiliated Companies the amount so required to be withheld as a condition of
the issuance, delivery, distribution or release of any Common Shares, and/or (iii) by causing the exercise or settlement of an Award and/or the sale of Common Shares held by or on behalf of an Israeli Participant to cover such liability, up to
the amount required to satisfy minimum statutory withholding requirements. In addition, the Israeli Participant will be required to pay any tax liability which exceeds the tax to be withheld and remitted to the tax authorities, pursuant to
applicable tax laws, regulations and rules. It is hereby further clarified that nothing in the potential adverse tax consequences to the Israeli Participants shall be deemed as restricting the Company from taking any action that it would have
otherwise be eligible to perform, including any of the actions delineated in Section 4.7 above, and, without limiting the generality of the foregoing, the Company makes no assurances, promises, undertakings or otherwise assumes any obligation
that it will seek the approval (whether prior or post factum) of the ITA with respect to any action taken, or contemplated to be taken, by the Company, including any of the actions delineated in Section 4.7 above (but subject to the obtainment
of prior approval of the ITA in the case of placing “put” and “call” option provisions in the Plan or the Appendix with respect to 102 Capital Gains Track Grants) and will not, in any case, be restricted in any way from taking
such action without the approval of the ITA, and such shall not derogate in any manner from the liability of each Israeli Participant to bear (solely on such Israeli Participant’s own) any tax consequences arising from, or related to, the grant
or exercise or vesting or settlement of any Award granted to such person. To the extent an Israeli Participant is or becomes subject to taxation in the United States, any Award granted hereunder is intended to be either exempt from or in
compliance with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code” and “Code Section 409A”, respectively), and any regulations or guidance that may
be adopted thereunder, and if an Israeli Participant is a “specified employee” as defined in Code Section 409A at the time of the Participant’s separation from service with the Company, then solely to

  
 6 

 
the extent necessary to avoid the imposition of any additional tax under Code Section 409A, the commencement of any payments or benefits under an Award shall be deferred until the date that
is six months following the Participant’s separation from service or such other period as required to comply with Code Section 409A. This provision shall not derogate in any manner from any of the other requirements hereunder and the
Participant shall be responsible for any tax consequences in the United States. 
 7.2    With respect
to Non-Trustee Grants, if the Eligible 102 Participant ceases to be employed by the Company or any Affiliated Company, the Eligible 102 Participant shall extend to the Company and/or its Affiliated Companies a
security or guarantee for the payment of tax due at the time of sale of Common Shares to the satisfaction of the Company, all in accordance with the provisions of Section 102 of the ITO and the ITO Rules. 

 

	 	8.	 Governing Law and Jurisdiction. 

The Plan and all Awards (including, without limitation, Options) granted thereunder are governed by the laws of the State of
Ohio without regards to conflicts of laws; provided, however, that all aspects of an Award which relate to Section 102 of the Ordinance, the rules and regulations promulgated thereunder, the Israeli Appendix, the Trust Agreement and/or
Section 3(i) of the Ordinance, shall be governed by and interpreted in accordance with the laws of the State of Israel and Section 102, in particular, with respect to Awards granted pursuant to Section 102 to Eligible 102
Participants, without regards to conflicts of laws. All Awards and Common Shares which are governed by the provisions of this Appendix shall be subject to the laws and requirements of the State of Israel and the terms and conditions on which any
such Award is granted are deemed modified to the extent necessary or advisable to comply with the applicable Israeli laws. It is hereby clarified that any ruling provided by the ITA with respect to Israeli Participants and is required in order for
the 102 Capital Gains Track Grants to continue to be subject to the 102 Capital Gains Track will be, upon the resolution of the Administrator, deemed incorporated into this Appendix such that the Administrator will be able to act in accordance with
such ruling. 
  

	 	9.	 Securities Laws. 

Without derogation from any provisions of the Plan, all Awards which are governed by the provisions of this Appendix shall
also be subject to compliance with the Israeli Securities Law, 1968, and the rules and regulations promulgated thereunder. 
 * * * * * * *

  
 7EX-10.7

 Exhibit 10.7 

MERIDIAN BIOSCIENCE, INC. 

2012 STOCK INCENTIVE PLAN 

RESTRICTED SHARE UNIT AWARD AGREEMENT 

TIME-BASED (U.S. EMPLOYEES) 

Summary of Restricted Share Unit Award Grant 

Meridian Bioscience, Inc., an Ohio corporation (the “Company”), grants to the Grantee named below, in accordance
with the terms of the Meridian Bioscience, Inc. 2012 Stock Incentive Plan (the “Plan”) and this Restricted Share Unit Award Agreement (the “Agreement”), the following number of Restricted Share Units of the Company (the
“Restricted Units”), on the Grant Date set forth below: 
  

							
		 	 Name of Grantee:
	  	                                     
                       	 	
				
	         
	 	 Number of Units:
	  	                                     
   	 	
				
		 	 Grant Date:
	  	November 5th, 2020        	 	
				
		 	 Vesting Date:
	  	November 15th, 2023      	 	

 Terms of Agreement 

1.        Grant of Restricted Share Unit Awards. Subject to and upon
the terms, conditions, and restrictions set forth in this Agreement and in the Plan, the Company hereby grants to the Grantee as of the Grant Date, the total number of Restricted Units set forth above. The Restricted Units shall be credited in a
book entry account established for the Grantee until payment in accordance with Section 4 hereof. 

2.        Vesting of Restricted Units. 

           (a)        Except
as otherwise provided in this Agreement, this grant of Restricted Units shall vest in full on the Vesting Date above. Prior to the Vesting Date, no portion of the award is vested, except as otherwise provided in Section 2(b) or (c). 

           (b)        All of
the Restricted Units shall vest in full prior to the Vesting Date upon the occurrence of any of the following: (i) the Grantee dies while in the employ of the Company; (ii) the Grantee satisfies the requirements for Retirement, including
separation from employment with the Company; (iii) the Grantee has a Disability; or (iv) there is a Change in Control event described in Section 2(g) of the Plan. 

           (c)        The
Committee may, in its sole discretion, accelerate the time at which the Restricted Units become vested and non-forfeitable to a time other than the Vesting Date as provided in Section 2(a) or to a time
other than provided in Section (2)(b)(i), (ii), (iii) or (iv) on such terms and conditions as it deems appropriate in accordance with the terms and conditions of the Plan, provided such acceleration does not result in an impermissible
acceleration of payments under Section 409A of the Code. 

3.        Forfeiture of Restricted Units. 

           (a)        The
Restricted Units that have not yet vested pursuant to Section 2 shall be forfeited automatically without further action or notice if the Grantee ceases to be employed by the Company other than as provided in Section 2(b) or
(c) hereof. 

           (b)        The
Grantee hereby acknowledges that in order for the Restricted Units to vest, Grantee must, prior to the first Vesting Date identified on the first page hereof under “Summary of Restricted Share Unit Award Grant”, (i) accept the Restricted
Units online or by telephone in accordance with the procedures established by the Company and Merrill Lynch, and; (ii) open a Merrill Lynch brokerage account through the system maintained on behalf of the Company. If the Grantee has not
completed both of the tasks prior to the first Vesting Date identified on the first page hereof under “Summary of Restricted Share Unit Award Grant”, the Restricted Units shall be forfeited as of such date. 

4.        Payment. 

           (a)        Except
as otherwise provided in this Agreement, the Company shall deliver to the Grantee one share of its common stock (“Share”) for each vested Restricted Unit within thirty (30) days following the earlier of: 

 

	 	(i)	 the Vesting Date identified on the first page hereof under “Summary of Restricted Share Unit Award
Grant”; 

  

	 	(ii)	 the date of the Grantee’s death; 

 

	 	(iii)	 the date of the Grantee’s Disability, provided such Disability also constitutes a
“disability” within the meaning of Section 409A of the Code with respect to a Grantee whose Restricted Units are subject to Section 409A of the Code; 

 

	 	(iv)	 the date of Grantee’s termination of employment with the Company as a result of Retirement or a
Change in Control event described in Section 2(g)(i) or (ii) of the Plan, provided such termination of employment also constitutes a “separation from service” within the meaning of Section 409A of the Code with respect to a
Grantee whose Restricted Units are subject to Section 409A of the Code; or 

  

	 	(v)	 the date of an event described in Section 2(g)(iii) or (iv) of the Plan, provided such event
also constitutes a “change in control event” within the meaning of Section 409A of the Code with respect to a Grantee whose Restricted Units are subject to Section 409A of the Code. 

If the Grantee is a “specified employee” within the meaning of Section 409A of the Code on the date of the Grantee’s
separation from service and the Grantee’s Restricted Units are subject to Section 409A of the Code, then payment under (iv) above shall be made on the first day of the seventh month following the Grantee’s separation from
service, or, if earlier, the date of the Grantee’s death. 

           (b)        The
Company’s obligations with respect to the Restricted Units shall be satisfied in full upon the delivery of its Shares pursuant to Section 4(a) herein. 

5.        Transferability. The Restricted Units may not be transferred
and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge, until all restrictions are removed or have expired, unless otherwise provided under the Plan. Any purported Transfer or encumbrance in violation of the
provisions of this Section 5 shall be void, and the other party to any such purported transaction shall not obtain any rights to or interest in such Restricted Units. 

6.        Voting and Other Rights. The Grantee will not have any
rights of a shareholder of the Company with respect to the Restricted Units until the delivery of the underlying Shares. The obligations of the Company under this Agreement will be merely that of an unfunded and unsecured promise of the Company to
deliver Shares in the future, and the rights of the Grantee will be no greater than that of an unsecured general 

  
 - 2 - 

 
creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Agreement. 

7.        Dividend Equivalent Payment Rights. The Grantee shall
possess no dividend equivalent payment rights with respect to the Restricted Units granted pursuant to this Agreement as of the Grant Date. 

8.        Continuous Employment. Unless otherwise specified by the
Plan, for purposes of this Agreement, the continuous employment of the Grantee with the Company shall not be deemed to have been interrupted, and the Grantee shall not be deemed to have ceased to be an employee of the Company, by reason of the
transfer of his employment among the Company or a leave of absence approved by the Committee. 

9.        No Employment Contract. Nothing contained in this Agreement
shall confer upon the Grantee any right with respect to continuance of employment by the Company, nor limit or affect in any manner the right of the Company to terminate the employment or adjust the compensation of the Grantee. 

10.        Relation to Other Benefits. Any economic or other benefit
to the Grantee under this Agreement or the Plan shall not be taken into account in determining any benefits to which the Grantee may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company and
shall not affect the amount of any life insurance coverage available to any beneficiary under any life insurance plan covering employees of the Company. 

11.        Taxes and Withholding. To the extent that the Company is
required to withhold any federal, state, local, foreign or other tax in connection with the Restricted Units or dividend equivalent payments thereon pursuant to this Agreement, it shall be a condition to earning the award that the Grantee make
arrangements satisfactory to the Company for payment of such taxes required to be withheld. With respect to payments under Section 4 herein, the Committee may, in its sole discretion, require the Grantee to satisfy such required withholding
obligation by surrendering to the Company a portion of the Shares earned by the Grantee hereunder, and the Shares so surrendered by the Grantee shall be credited against any such withholding obligation at the Fair Market Value of such Shares on the
date of surrender. Further, the Committee may accelerate the payment of a portion of the Shares earned by the Grantee hereunder to pay the Federal Insurance Contributions Act (FICA) tax under Sections 3101, 3121(a) and 3121(v)(2) of the Code and the
corresponding income tax withholding related to the FICA amount. 

12.        Adjustments. The number and kind of Shares deliverable
pursuant to a Restricted Unit are subject to adjustment as provided in Section 8 of the Plan. 

13.        Compliance with Law. While the Company shall make
reasonable efforts to comply with all applicable federal and state securities laws and listing requirements with respect to the Restricted Units or Shares that may be delivered pursuant to Section 4 herein, the Company shall not be obligated to
deliver any Restricted Units or Shares pursuant to this Agreement if the delivery thereof would result in a violation of any such law or listing requirement. 

14.        Amendments. Subject to the terms of the Plan, the Committee
may modify this Agreement upon written notice to the Grantee. Any amendment to the Plan shall be deemed to be an amendment to this Agreement to the extent that the amendment is applicable hereto; provided, however, no amendment of the
Plan or this Agreement shall adversely affect the rights of the Grantee under this Agreement without the Grantee’s consent unless the Committee determines, in good faith, that such amendment is required for the Agreement to either be exempt
from the application of, or comply with, the requirements of Section 409A of the Code, or as otherwise may be provided in the Plan. 

15.        Section 409A of the Code. It is intended that the
Restricted Units shall be exempt from the application of, or comply with, the requirements of Section 409A of the Code. The terms of this Agreement shall be construed, administered, and governed in a manner that effects such intent, and the
Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Restricted Units 

  
 - 3 - 

 
shall not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an
applicable exception from the requirements of Section 409A of the Code or otherwise would subject the Grantee to the additional tax imposed under Section 409A of the Code. 

16.        Severability. In the event that one or more of the
provisions of this Agreement shall be invalidated for any reason by a court of competent jurisdiction, any provision so invalidated shall be deemed to be separable from the other provisions hereof, and the remaining provisions hereof shall continue
to be valid and fully enforceable. 
 17.        Relation to Plan.
This Agreement is subject to the terms and conditions of the Plan. This Agreement and the Plan contain the entire agreement and understanding of the parties with respect to the subject matter contained in this Agreement, and supersede all prior
written or oral communications, representations and negotiations in respect thereto. In the event of any inconsistency between the provisions of this Agreement and the Plan, the Plan shall govern except with respect to Section 2(a) of this
Agreement. Capitalized terms used herein without definition shall have the meanings assigned to them in the Plan. The Committee acting pursuant to the Plan, as constituted from time to time, shall, except as expressly provided otherwise herein, have
the right to determine any questions which arise in connection with the grant of the Restricted Units. 

18.        Successors and Assigns. Without limiting Section 5,
the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, administrators, heirs, legal representatives and assigns of the Grantee, and the successors and assigns of the Company. 

19.        No Advice Regarding Award. The Company is not
providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Grantee’s participation in the Plan or the acquisition or sale of the underlying securities. The Grantee is hereby advised to consult with
the Grantee’s personal tax, legal or financial advisors regarding the decision to participate in the Plan before taking any action related to the Plan. 

20.        Governing Law. 

           (a)        The
interpretation, performance, and enforcement of this Agreement, including tort claims, shall be governed by the laws of the State of Ohio, without giving effect to the principles of conflict of laws thereof. 

           (b)        Any
party bringing a legal action or proceeding against another party arising out of or relating to this Agreement may bring the legal action or proceeding only in the United States District Court for the Southern District of Ohio and any of the courts
of the State of Ohio, in each case sitting in Cincinnati, Ohio. 

           (c)        Each
of the Company and the Grantee waives, to the fullest extent permitted by law, (i) any objection which it may now or later have to the laying of venue of any legal action or proceeding arising out of or relating to this Agreement brought in any
court of the State of Ohio sitting in Cincinnati, Ohio or the United States District Court for the Southern District of Ohio sitting in Cincinnati, Ohio, including, without limitation, a motion to dismiss on the grounds of forum non
conveniens or lack of subject matter jurisdiction; and (ii) any claim that any action or proceeding brought in any such court has been brought in an inconvenient forum. 

           (d)    Each of the Company and the
Grantee submits to the exclusive jurisdiction (both personal and subject matter) of (i) the United States District Court for the Southern District of Ohio sitting in Cincinnati, Ohio and its appellate courts, and (ii) any court of the
State of Ohio sitting in Cincinnati, Ohio and its appellate courts, for the purposes of all legal actions and proceedings arising out of or related to this Agreement. 

  
 - 4 - 

 21.        Language.
If the Grantee receives this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control. 

22.        Electronic Delivery. The Grantee hereby consents and agrees
to electronic delivery of any documents that the Company may elect to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports, and
all other forms of communications) in connection with this and any other award made or offered under the Plan. The Grantee understands that, unless earlier revoked by the Grantee by giving written notice to the Secretary of the Company, this consent
shall be effective for the duration of the Agreement. The Grantee also understands that he or she shall have the right at any time to request that the Company deliver written copies of any and all materials referred to above at no charge. The
Grantee hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Company may elect to deliver, and agrees that his or her
electronic signature is the same as, and shall have the same force and effect as, his or her manual signature. The Grantee consents and agrees that any such procedures and delivery may be effected by a third party engaged by the Company to provide
administrative services related to the Plan. 
 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed
on its behalf by its duly authorized officer and the Grantee has also executed this Agreement, as of the Grant Date. 
  

			
	MERIDIAN BIOSCIENCE, INC.	  	
		
	By:                                     
                       	  	        
	Name: Bryan T. Baldasare	  	
	Title: Chief Financial Officer	  	

  
 - 5 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]